Study of Low-intensity Focused Ultrasound Effects on Human Memory
1 other identifier
interventional
80
1 country
1
Brief Summary
This research project is examining the effects of noninvasive brain stimulation on human memory. This study will help to better understand noninvasive brain stimulation techniques that may have the potential to aid in memory dysfunction. Subjects will undergo a magnetic resonance imaging (MRI) and a computed tomography (CT) scan, to take pictures of their brain and skull. They will receive noninvasive brain stimulation using low-intensity focused ultrasound (LIFU) sound waves, to temporarily change brain activity. Their brain signals (MRI or EEG) will be monitored to measure changes in their brain signals. Their heart rate, blood pressure, respiratory rate, eye movement and skin moisture will be monitored as well. They will complete neuropsychological batteries and memory tasks. They will complete questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2024
CompletedFirst Posted
Study publicly available on registry
October 4, 2024
CompletedStudy Start
First participant enrolled
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
March 31, 2026
March 1, 2026
2 years
September 23, 2024
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Memory Task Accuracy
The percentage of correct responses during memory recall tasks, measured as a percentage. This metric will evaluate accuracy following LIFU stimulation compared to sham stimulation.
up to 6 weeks
Memory Task Reaction Time
Reaction time during memory recall tasks, measured in milliseconds. This metric will assess the speed of memory recall following LIFU stimulation compared to sham stimulation.
up to 6 weeks
Secondary Outcomes (5)
Electroencephalography(EEG) Power Spectral Analysis in Targeted Brain Regions
up to 6 weeks
Phase-Amplitude Coupling (PAC) Index
up to 6 weeks
Executive Function Score
up to 6 weeks
Attention Score
up to 6 weeks
Processing Speed Score
up to 6 weeks
Study Arms (8)
Sham LIFU
SHAM COMPARATORSham LIFU stimulation visit with memory tasks and neuropsychological assessments.
LIFU 1
EXPERIMENTALLIFU stimulation with parameter set 1 visit with memory tasks and neuropsychological assessments.
LIFU 2
EXPERIMENTALLIFU stimulation with parameter set 2 visit with memory tasks and neuropsychological assessments.
LIFU 3
EXPERIMENTALLIFU stimulation with parameter set 3 visit with memory tasks and neuropsychological assessments.
LIFU 4
EXPERIMENTALLIFU stimulation with parameter set 4 visit with memory tasks and neuropsychological assessments.
LIFU 5
EXPERIMENTALLIFU stimulation with parameter set 5 visit with memory tasks and neuropsychological assessments.
LIFU 6
EXPERIMENTALLIFU stimulation with parameter set 6 visit with memory tasks and neuropsychological assessments.
LIFU 7
EXPERIMENTALLIFU stimulation with parameter set 7 visit with memory tasks and neuropsychological assessments.
Interventions
low-intensity focused ultrasound for neuromodulation applied to the head.
Eligibility Criteria
You may qualify if:
- Subjects of all ethnicities, who understand and speak English.
You may not qualify if:
- Claustrophobia (scanning environment may be uncomfortable).
- Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
- Contraindications to CT: pregnancy
- Active medical disorder or treatment with potential CNS effects (e.g. Alzheimer\'s)
- History of neurologic disorder. (e.g. Parkinson\'s, Epilepsy, or Essential Tremor)
- History of head injury resulting in loss of consciousness for \>10 minutes.
- History of alcohol or drug dependence (through self-report).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 23, 2024
First Posted
October 4, 2024
Study Start
November 18, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
March 31, 2026
Record last verified: 2026-03